Method of separating short half-life radionuclides from a mixture of radionuclides
Description
The present invention is a method of removing an impurity of plutonium, lead or a combination thereof from a mixture of radionuclides that contains the impurity and at least one parent radionuclide. The method has the steps of (a) insuring that the mixture is a hydrochloric acid mixture; (b) oxidizing the acidic mixture and specifically oxidizing the impurity to its highest oxidation state; and (c) passing the oxidized mixture through a chloride form anion exchange column whereupon the oxidized impurity absorbs to the chloride form anion exchange column and the 229Th or 227Ac ''cow'' radionuclide passes through the chloride form anion exchange column. The plutonium is removed for the purpose of obtaining other alpha emitting radionuclides in a highly purified form suitable for medical therapy. In addition to plutonium, lead, iron, cobalt, copper, uranium, and other metallic cations that form chloride anionic complexes that may be present in the mixture are removed from the mixture on the chloride form anion exchange column. 8 figs
Availability note (English)
Available from Patent and Trademark Office, Box 9, Washington, DC 20232 (United States)Additional details
Publishing Information
- Imprint Pagination
- [10 p.]
- IPC:
- Int. Cl. C02F 1/42
- IPC
- Int. Cl. C02F 1/42
- Patent number
- US patent document 5,885,465/A/
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 30036046
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE; S38: RADIATION CHEMISTRY, RADIOCHEMISTRY AND NUCLEAR CHEMISTRY;
- Resource subtype / Literary indicator
- Non-conventional Literature
- Descriptors DEI
- ACTINIUM 227; CHLORINATION; COBALT; COPPER; ION EXCHANGE; LEAD; OXIDATION; PLUTONIUM; PURIFICATION; RADIOPHARMACEUTICALS; THORIUM 229; URANIUM
- Descriptors DEC
- ACTINIDE NUCLEI; ACTINIDES; ACTINIUM ISOTOPES; ALPHA DECAY RADIOISOTOPES; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; CHEMICAL REACTIONS; DRUGS; ELEMENTS; EVEN-ODD NUCLEI; HALOGENATION; HEAVY NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; METALS; NUCLEI; ODD-EVEN NUCLEI; RADIOACTIVE MATERIALS; RADIOISOTOPES; THORIUM ISOTOPES; TRANSITION ELEMENTS; TRANSURANIUM ELEMENTS; YEARS LIVING RADIOISOTOPES
Optional Information
- Funding organization
- USDOE, Washington, DC (United States)